Chromatin Remodeling in Mammary Gland Differentiation and Breast Tumorigenesis

被引:23
作者
Huang, Tim H. -M. [1 ]
Esteller, Manel [2 ]
机构
[1] Ohio State Univ, Human Canc Genet Program, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43220 USA
[2] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona, Catalonia, Spain
来源
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY | 2010年 / 2卷 / 09期
基金
美国国家卫生研究院;
关键词
DNA METHYLATION PATTERNS; CPG ISLAND; EPITHELIAL-CELLS; ABERRANT EXPRESSION; ESTROGEN-RECEPTOR; CANCER-CELLS; GENE-EXPRESSION; HISTONE H4; GENOME; WIDE;
D O I
10.1101/cshperspect.a004515
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
DNA methylation and histone modifications have essential roles in remodeling chromatin structure of genes necessary for multi-lineage differentiation of mammary stem/progenitor cells. The role of this well-defined epigenetic programming is to heritably maintain transcriptional plasticity of these loci over multiple cell divisions in the differentiated progeny. Epigenetic events can be deregulated in progenitor cells chronically exposed to xenoestrogen or inflammatory microenvironment. In addition, epigenetically mediated silencing of genes associated with tumor suppression can take place, resulting in clonal proliferation of undifferentiated or semidifferentiated cells. Alternatively, microRNAs that negatively regulate the expression of their protein-coding targets may become epigenetically repressed, leading to oncogenic expression of these genes. Here we further discuss interactions between DNA methylation and histone modifications that have significant contributions to the differentiation of mammary stem/progenitor cells and to tumor initiation and progression.
引用
收藏
页数:16
相关论文
共 111 条
  • [1] NUMBER OF CPG ISLANDS AND GENES IN HUMAN AND MOUSE
    ANTEQUERA, F
    BIRD, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) : 11995 - 11999
  • [2] CpG islands as genomic footprints of promoters that are associated with replication origins
    Antequera, F
    Bird, A
    [J]. CURRENT BIOLOGY, 1999, 9 (17) : R661 - R667
  • [3] New anti-cancer strategies: Epigenetic therapies and biomarkers
    Balch, C
    Montgomery, JS
    Paik, HI
    Kim, S
    Huang, THM
    Nephew, KP
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 : 1897 - 1931
  • [4] Epigenetic "bivalently marked" process of cancer stem cell-driven tumorigenesis
    Balch, Curt
    Nephew, Kenneth P.
    Huang, Tim H. -M.
    Bapat, Sharmila A.
    [J]. BIOESSAYS, 2007, 29 (09) : 842 - 845
  • [5] Balch Curt, 2008, P197
  • [6] Ballestar E, 2005, PROG MOLEC, V38, P169
  • [7] Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer
    Ballestar, E
    Paz, MF
    Valle, L
    Wei, S
    Fraga, MF
    Espada, J
    Cigudosa, JC
    Huang, THM
    Esteller, M
    [J]. EMBO JOURNAL, 2003, 22 (23) : 6335 - 6345
  • [8] High-resolution profiling of histone methylations in the human genome
    Barski, Artern
    Cuddapah, Suresh
    Cui, Kairong
    Roh, Tae-Young
    Schones, Dustin E.
    Wang, Zhibin
    Wei, Gang
    Chepelev, Iouri
    Zhao, Keji
    [J]. CELL, 2007, 129 (04) : 823 - 837
  • [9] Histone deacetylase inhibitors as anti-neoplastic agents
    Batty, Nicolas
    Malouf, Gabriel G.
    Issa, Jean Pierre J.
    [J]. CANCER LETTERS, 2009, 280 (02) : 192 - 200
  • [10] The DNA methyltransferases of mammals
    Bestor, TH
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (16) : 2395 - 2402